Hongqi Liu
NHC Key Laboratory Of Human Disease Comparative Medicine, State Key Laboratory Of Respiratory Health And Multimorbidity, And Key Laboratory Of Pathogen Infection Prevention And Control, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Advances and perspectives for animal models of chikungunya virus infection.
Journal: Biosafety and health
Published: August 16, 2025
Identification of RACK1 as a novel regulator of non-structural protein 4 of chikungunya virus.
Journal: Acta biochimica et biophysica Sinica
Published: May 30, 2024
Gastrointestinal microbiota and metabolites possibly contribute to distinct pathogenicity of SARS-CoV-2 proto or its variants in rhesus monkeys.
Journal: Gut microbes
Published: April 02, 2024
Human transferrin receptor can mediate SARS-CoV-2 infection.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 26, 2024
Attenuation of relapsing fever neuroborreliosis in mice by IL-17A blockade.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 10, 2022
Genetic Characterization of Chikungunya Virus Among Febrile Dengue Fever-Like Patients in Xishuangbanna, Southwestern Part of China.
Journal: Frontiers in cellular and infection microbiology
Published: April 06, 2022
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.
Journal: Signal transduction and targeted therapy
Published: January 23, 2022
Preparation and application of chikungunya pseudovirus containing double reporter genes.
Journal: Scientific reports
Published: November 30, 2021
Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
Journal: Emerging microbes & infections
Published: October 20, 2021
Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
Journal: Frontiers in immunology
Published: April 21, 2021
Last Updated: 09/26/2026